Aligos Therapeutics Inc.

04/03/2025 | Press release | Distributed by Public on 04/04/2025 04:02

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 3, 2025 4:00 P.M.
Form: S-3
CIK: 0001799448
Company Name: Aligos Therapeutics, Inc.
File Number: 333-286168
Aligos Therapeutics Inc. published this content on April 03, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on April 04, 2025 at 10:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]